Tilray Brands (TLRY) Total Liabilities (2017 - 2026)
Tilray Brands' (TLRY) quarterly Total Liabilities came in at $733.1 million in Q2 2026, up 25.38% YoY from $584.8 million in Q2 2025, and up 33.51% on a QoQ basis from $549.1 million in Q1 2026.
Tilray Brands (TLRY) Total Liabilities (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Total Liabilities data on file, last reported at $733.1 million in Q2 2026.
- Quarterly Total Liabilities rose 25.38% year-over-year to $733.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $733.1 million (up 25.38% YoY) and the FY2026 annual result came in at $733.1 million, up 25.38% from the prior year.
- Total Liabilities climbed to $733.1 million in Q2 2026, from $549.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.2 billion in Q1 2022 to a low of $549.1 million in Q1 2026.
- A 5-year average of $836.3 million and a median of $869.8 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities tumbled 35.69% — and 2026, when it gained 25.38%.
- Tracing TLRY's Total Liabilities over 5 years: stood at $991.2 million in 2022, then decreased by 5.45% to $937.2 million in 2023, then dropped by 21.24% to $738.1 million in 2024, then slipped by 25.21% to $552.1 million in 2025, then jumped by 32.79% to $733.1 million in 2026.
- The last three Total Liabilities figures came in at $733.1 million (Q2 2026), $549.1 million (Q1 2026), and $552.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 2.12 Bn |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn | 733.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 733.15 Mn |
| Feb 28, 2026 | 549.12 Mn |
| Nov 30, 2025 | 552.09 Mn |
| Aug 31, 2025 | 561.99 Mn |
| May 31, 2025 | 584.75 Mn |
| Nov 30, 2024 | 738.15 Mn |
| Aug 31, 2024 | 778.45 Mn |
| May 31, 2024 | 778.49 Mn |
| Feb 29, 2024 | 869.82 Mn |
| Nov 30, 2023 | 937.20 Mn |
| Aug 31, 2023 | 1.00 Bn |
| May 31, 2023 | 977.32 Mn |
| Feb 28, 2023 | 969.13 Mn |
| Nov 30, 2022 | 991.23 Mn |
| Aug 31, 2022 | 1.03 Bn |
| May 31, 2022 | 1.01 Bn |
| Feb 28, 2022 | 1.16 Bn |
| Nov 30, 2021 | 1.29 Bn |
| Aug 31, 2021 | 1.60 Bn |
| May 31, 2021 | 1.56 Bn |